Royal Pharmaceutical Society (RPS) - News updates

Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly

Date confirmed for delayed registration assessment

We have welcomed the announcement by the GPhC that its delayed registration assessment will take place on 17 and 18 March 2021, and is calling for further details to be clarified as quickly as possibl

RPS announces updated membership fees for 2021

The Royal Pharmaceutical Society today announced its new fees for all members in 2021. The big news is a 9% saving for members joining via annual Direct Debit. Robbie Turner, RPS Director of Member

COVID-19 vaccination resources

Public Health England has issued provisional guidance on COVID-19 in the green book, chapter 14a. This is provisional as it is subject to MHRA approval of vaccine supply. The chapter contains informat

RPS Scotland celebrates new Fellows

RPS Director for Scotland, Clare Morrison and SPB Chair, Jonathan Burton have written to the nine new pharmacists in Scotland who have received Fellowships, congratulating them on their well-deserved

Impact of COVID-19 on pharmacists' mental health and wellbeing

RPS, in partnership with charity Pharmacist Support, have today published their second annual survey onmental health and wellbeing, which demonstratesthe impact of COVID-19 on pharmacists. Over half

COVID-19 second wave letter from CPhOs and regulators

The UK's Chief Pharmaceutical Officers and pharmacyregulatorshavewritten a joint letter on supporting pharmacists, pharmacy technicians and pharmacy teams throughout the second COVID-19 wave. The

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Largactil 50mg/2ml Solution for Injection

Sanofi is recalling specific batches of Largactil 50mg/2ml Solution for Injection as a precautionary measure due to out of specification results obtained for the impurity chlorpromazine sulphoxide. F

RPS mental health and wellbeing report – Scotland’s Interim CPhO responds

In response to our mental health and wellbeing report, Scotland's Interim Chief Pharmaceutical Officer Alison Strath has sent us the following message: “Having good mental health, or being

Class 2 Medicines Recall: Kent Pharmaceuticals Ltd, Betahistine dihydrochloride 8mg and 16mg Tablets

Kent Pharmaceuticals Ltd is recalling several batches, due to finished products being contaminated with theophylline due to a cross-contamination issue identified with an excipient that was used in th

We respond to the Spending Review

Responding to today’s Spending Review, Claire Anderson, Chair of the RPS in England said: “I welcome the Chancellor’s continued determination to support efforts to tackle COVID-19 a